Important Notice – New Certificates Required for Access to the CZMVS

Please note an important requirement related to access to the CZMVS system.

In mid-May this year (approximately May 18–20, 2026), a new version of the CZMVS system (release R18) will be deployed.

Due to a change in the CA certification authority used by the SSL certificate provider, it will be necessary for all devices connecting to the CZMVS system to have two new security certificates installed by the implementation date of the new release at the latest.

Without their installation, it will not be possible to log into the system or perform operations with medicinal products!

Required certificates:

•     Root certificate authority: Sectigo Public Server Authentication Root R46

•     Subordinate certificate authority: Sectigo Public Server Authentication CA DV R36

Notes:

  1. If a pharmacy or distributor uses an FMD application on a local device that communicates directly with CZMVS, it is necessary to check whether the device has both required certificates registered.
  2. If a pharmacy chain or distributor uses a device whose FMD application connects to a central system that then communicates with CZMVS, it is sufficient to check the central system.
  3. Regularly updated Windows operating systems should already contain these certificates. Linux- or Java-based environments may not contain them, and manual installation may be necessary.

All software companies providing FMD solutions on the Czech market have already received this information and should be able to respond to any questions or requests from users.

CZMVO (NOOL) is currently preparing a simple user verification to check whether the required certificates are correctly installed on individual devices, and will also publish general instructions for installing them if they are missing from the device. This will be available on our website immediately after the implementation of CZMVS R18 into the IQE environment (around March 19, 2026).

The NOOL, z.s. team,

Founding members

Associate members

© Copyright 2026 Národní organizace pro ověřování pravosti léčiv, z.s
editorial system Kompletweb | Neofema, s.r.o.